Economics of antihypertensive therapy in the elderly

Drugs and Aging

Volumn 18, Issue 7, 2001, Pages 515-525

  Dunn, E C ^a   Small, R E ^b  

^a MIDWESTERN UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

AGED; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; ELDERLY CARE; HEART INFARCTION; HUMAN; HYPERTENSION; MAINTENANCE THERAPY; MEDICAL DECISION MAKING; MORBIDITY; MORTALITY; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; TREATMENT OUTCOME;

EID: 0034928046     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-200118070-00005     Document Type: Review

References (36)

1. Guidelines for performing a pharmacoeconomic analysis
2. The health economics of the treatment of hyperlipidemia and hypertension
3. Cost benefit of treating hypertension
4. Allocation of resources to manage hypertension
5. The cost-effectiveness of treating mild-to-moderate hypertension: A reappraisal
6. The impact of age on cost-effectiveness of hypertension treatment: An analysis of randomized drug trials
7. The cost-effectiveness of treating hypertension in elderly people: An analysis of the Swedish Trial in Old Patients with Hypertension (STOP Hypertension)
8. Moderately elevated blood pressure a report from SBU
9. Risks of untreated and treated isolated systolic hypertension in the elderly: Meta-analysis of outcome trials
10. Evaluation of cardiovascular risk in the elderly: The Framingham Study
11. 1999 World Health Organizations-International Society of Hypertension guidelines for the management of hypertension
12. Does the benefit of antihypertensive treatment outweigh the risk in very elderly hypertensive patients?
13. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension
14. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (TOP-Hypertension)
15. Randomised trial of old and new antihypertensive drugs in elderly patients: Cardiovascular mortality and morbidity in the Swedish Trial in Old Patients with Hypertension-2 study
16. Medical Research Council trial of treatment of hypertension in older adults: Principal results
17. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
18. Are β-blockers efficacious as first-line therapy for hypertension in the elderly?
19. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly Trial
20. Antihypertensive drugs in very old people: A subgroup meta-analysis of randomised controlled trials
21. Hypertension in the Very Elderly Trial (HYVET): Protocol for the main trial
22. Cost-effectiveness analysis in the treatment of hypertension: A medical view
23. Effects of an angiotensin converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
24. Cardiovascular pharmacology of aging
25. Economics of hypertension control: A statement by the World Hypertension League
26. Trends in pharmacologic management of hypertension in the United States
27. Single-drug therapy for hypertension in men
28. Prescribing for elderly: Sensitivity of the elderly to adverse drug reactions
29. Management of hypertension in older persons
30. Task Force IV: Clinical use of ambulatory blood pressure monitoring. Participants of the 1999 Consensus Conference on Ambulatory Blood Pressure Monitoring
31. "White-coat" hypertension in patients with newly diagnosed hypertension: Evaluation of prevalence by ambulatory monitoring and impact on cost of health care
32. Consensus conference on self-blood pressure measurement
33. National High Blood Pressure Education Program Working Group report on hypertension in the elderly
34. Three important subgroups of hypertensive persons at greater risk of intracerebral hemorrhage
35. Effectiveness of interventions to improve patient compliance: A meta-analysis